Marcus J. Calkins, Ph.D. - Publications

University of Wisconsin, Madison, Madison, WI 
visual working memory, attention, dynamical systems approaches to cognition

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Tsai SF, Chen PC, Calkins MJ, Wu SY, Kuo YM. Exercise Counteracts Aging-Related Memory Impairment: A Potential Role for the Astrocytic Metabolic Shuttle. Frontiers in Aging Neuroscience. 8: 57. PMID 27047373 DOI: 10.3389/fnagi.2016.00057  0.36
2015 Hsu CY, Lin CH, Jan YH, Su CY, Yao YC, Cheng HC, Hsu TI, Wang PS, Su WP, Yang CJ, Huang MS, Calkins MJ, Hsiao M, Lu PJ. HIP1 is an Early-stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated EMT. American Journal of Respiratory and Critical Care Medicine. PMID 26595459 DOI: 10.1164/rccm.201412-2226OC  0.36
2013 Jacobs AC, Calkins MJ, Jadhav A, Dorjsuren D, Maloney D, Simeonov A, Jaruga P, Dizdaroglu M, McCullough AK, Lloyd RS. Inhibition of DNA glycosylases via small molecule purine analogs. Plos One. 8: e81667. PMID 24349107 DOI: 10.1371/journal.pone.0081667  0.36
2012 Calkins MJ, Manczak M, Reddy PH. Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). 5: 1103-19. PMID 23226091 DOI: 10.3390/ph5101103  0.36
2012 Mao P, Manczak M, Calkins MJ, Truong Q, Reddy TP, Reddy AP, Shirendeb U, Lo HH, Rabinovitch PS, Reddy PH. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. Human Molecular Genetics. 21: 2973-90. PMID 22492996 DOI: 10.1093/hmg/dds128  0.36
2012 Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, Manczak M. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochimica Et Biophysica Acta. 1822: 639-49. PMID 22037588 DOI: 10.1016/j.bbadis.2011.10.011  0.36
2012 Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Human Molecular Genetics. 21: 406-20. PMID 21997870 DOI: 10.1093/hmg/ddr475  0.36
2011 Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Human Molecular Genetics. 20: 4515-29. PMID 21873260 DOI: 10.1093/hmg/ddr381  0.36
2011 Calkins MJ, Reddy PH. Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage. Biochimica Et Biophysica Acta. 1812: 1182-9. PMID 21549836 DOI: 10.1016/j.bbadis.2011.04.006  0.36
2011 Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Human Molecular Genetics. 20: 2495-509. PMID 21459773 DOI: 10.1093/hmg/ddr139  0.36
2011 Reddy TP, Manczak M, Calkins MJ, Mao P, Reddy AP, Shirendeb U, Park B, Reddy PH. Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31. International Journal of Environmental Research and Public Health. 8: 203-21. PMID 21318024 DOI: 10.3390/ijerph8010203  0.36
2011 Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Human Molecular Genetics. 20: 1438-55. PMID 21257639 DOI: 10.1093/hmg/ddr024  0.36
2011 Calkins MJ, Reddy PH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochimica Et Biophysica Acta. 1812: 507-13. PMID 21241801 DOI: 10.1016/j.bbadis.2011.01.007  0.36
2011 Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Research Reviews. 67: 103-18. PMID 21145355 DOI: 10.1016/j.brainresrev.2010.11.004  0.36
2010 Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. Journal of Alzheimer's Disease : Jad. 20: S609-31. PMID 20463406 DOI: 10.3233/JAD-2010-100564  0.36
2010 Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. Journal of Alzheimer's Disease : Jad. 20: S499-512. PMID 20413847 DOI: 10.3233/JAD-2010-100504  0.36
2010 Calkins MJ, Townsend JA, Johnson DA, Johnson JA. Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Experimental Neurology. 224: 307-17. PMID 20406637 DOI: 10.1016/j.expneurol.2010.04.008  0.36
2010 Calkins MJ, Vargas MR, Johnson DA, Johnson JA. Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicological Sciences : An Official Journal of the Society of Toxicology. 115: 557-68. PMID 20211941 DOI: 10.1093/toxsci/kfq072  0.36
2009 Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee JM, Li J, Johnson JA. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxidants & Redox Signaling. 11: 497-508. PMID 18717629 DOI: 10.1089/ARS.2008.2242  0.36
2008 Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Annals of the New York Academy of Sciences. 1147: 61-9. PMID 19076431 DOI: 10.1196/annals.1427.036  0.36
2007 Li J, Calkins MJ, Johnson DA, Johnson JA. Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection. Methods in Molecular Biology (Clifton, N.J.). 399: 67-78. PMID 18309926 DOI: 10.1007/978-1-59745-504-6_6  0.36
2005 Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. Nrf2, a multi-organ protector? Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1061-6. PMID 15985529 DOI: 10.1096/fj.04-2591hyp  0.4
2005 Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America. 102: 244-9. PMID 15611470 DOI: 10.1073/pnas.0408487101  0.36
2003 Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. The Journal of Biological Chemistry. 278: 12029-38. PMID 12556532 DOI: 10.1074/jbc.M211558200  0.4
Show low-probability matches.